The Flemingsberg Science Foundation is present at Almedalen Week!

We’re back in Almedalen this year – with a strong focus on Flemingsberg and life science!
Our program includes a follow-up to last year’s roundtable discussion on Flemingsberg’s role in positioning southern Stockholm as a world-leading life science hub. We’re also taking part in a panel discussion on successful life science clusters. Don’t miss our seminars – and make sure to stop by and say hello!

Here’s where you can find us during the week:

Tuesday:

Co-hosts of the Innovation Mingle with SISP – Swedish Incubators & Science Parks

Wednesday:

08:00–09:00
Infections in a New World Order with Hybrid Warfare
Rostockergränd 3, “Fabegeträdgården”
Organized by: Karolinska Institutet & Flemingsberg Science Foundation
Find in the program

10:45–12:00
Workshop: Capital of Life – an Investment in the Future for Everyone
Where? Östra Tullgränd 10, Visby
Organized by: Stockholm-Uppsala Life Science Cluster
Read more

Thursday:

Roundtable (by invitation only):
Flemingsberg’s importance in establishing southern Stockholm as a world-leading life science region.
Organized by: Huddinge Municipality & Flemingsberg Science Foundation

Roundtable Discussion (by invitation only)
How can we increase visibility and attract more investments to the Stockholm-Uppsala life science cluster in the field of ATMP?
Organized by: Stockholm-Uppsala Life Science Cluster

14:30–15:30
Panel Discussion: Successful Life Science Clusters
Rostockergränd 3, “Fabegeträdgården”
Organized by: Fabege
Find in the program

 

OptiCell Solutions – A Key Player in Cell and Gene Therapy Establishes in Flemingsberg

Flemingsberg continues to be a natural choice for knowledge-intensive and innovative businesses. OptiCell Solutions is a company that recently launched its operations at Novum Labs on the Flemingsberg Campus. Founded in 2024 by specialists from Karolinska University Hospital and entrepreneurs from the Life Science industry, the company specializes in improving the availability of high-quality target cells for cell and gene therapies, a critical component of the growing ATMP (Advanced Therapy Medicinal Products) sector.

Go to Top